Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhEGF for Oral Mucositis in Hematologic Malignancies
NCT00845819Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2009
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nepidermin in oral mucositis (OM), sponsored by Seoul National University Hospital. Started Feb 2009; status: completed.
02
Drugs
nepidermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00845819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845819.